Daftar Login

Mito-99-0103Drug Targets, Indications, Patents

MEREK : mito99

Mito-99-0103Drug Targets, Indications, Patents

mito99Mito-99-0103Mito BioPharm LLC (Mito BioPharm LLC): : 2: MitoMito-99-0103, Initially developed by Mito BioPharm LLC, Now, its global hhest R&D status is Preclinical, Therapeutic Areas: Endocrinology and Metabolic Disease, Active Indication:

IDR 10.000
IDR 100.000 Disc -90%
Kuantitas